JP2023518376A5 - - Google Patents

Info

Publication number
JP2023518376A5
JP2023518376A5 JP2022555836A JP2022555836A JP2023518376A5 JP 2023518376 A5 JP2023518376 A5 JP 2023518376A5 JP 2022555836 A JP2022555836 A JP 2022555836A JP 2022555836 A JP2022555836 A JP 2022555836A JP 2023518376 A5 JP2023518376 A5 JP 2023518376A5
Authority
JP
Japan
Application number
JP2022555836A
Other languages
Japanese (ja)
Other versions
JP2023518376A (ja
JPWO2021184062A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2021/050229 external-priority patent/WO2021184062A1/en
Publication of JP2023518376A publication Critical patent/JP2023518376A/ja
Publication of JPWO2021184062A5 publication Critical patent/JPWO2021184062A5/ja
Publication of JP2023518376A5 publication Critical patent/JP2023518376A5/ja
Withdrawn legal-status Critical Current

Links

JP2022555836A 2020-03-16 2021-03-16 気道感染症を治療するための組成物およびそれらの使用 Withdrawn JP2023518376A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2020900807 2020-03-16
AU2020900807A AU2020900807A0 (en) 2020-03-16 Compositions for treating respiratory tract infection and uses thereof
AU2020900818 2020-03-17
AU2020900818A AU2020900818A0 (en) 2020-03-17 Compositions for treating respiratory tract infection and uses thereof
AU2020904226 2020-11-16
AU2020904226A AU2020904226A0 (en) 2020-11-16 Compositions for treating respiratory tract infection and uses thereof
PCT/AU2021/050229 WO2021184062A1 (en) 2020-03-16 2021-03-16 Compositions for treating respiratory tract infection and uses thereof

Publications (3)

Publication Number Publication Date
JP2023518376A JP2023518376A (ja) 2023-05-01
JPWO2021184062A5 JPWO2021184062A5 (https=) 2024-03-27
JP2023518376A5 true JP2023518376A5 (https=) 2024-03-27

Family

ID=77767913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022555836A Withdrawn JP2023518376A (ja) 2020-03-16 2021-03-16 気道感染症を治療するための組成物およびそれらの使用

Country Status (7)

Country Link
US (1) US20230256059A1 (https=)
EP (1) EP4121084A4 (https=)
JP (1) JP2023518376A (https=)
CN (1) CN115297882A (https=)
AU (1) AU2021237981A1 (https=)
CA (1) CA3171917A1 (https=)
WO (1) WO2021184062A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021003531A1 (en) * 2019-07-09 2021-01-14 Lateral IP Pty Ltd Peptides and uses thereof
JP2024516327A (ja) * 2021-05-07 2024-04-12 ラテラル、ファーマ、プロプライエタリー、リミテッド 炎症性気道疾患を処置するための組成物及びその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20080333A0 (fi) * 2008-05-02 2008-05-02 Glykos Finland Oy Influenssaviruksen nukleiinihappoja ja peptidejä
BR112014013757A2 (pt) * 2011-12-09 2019-08-27 Metabolic Pharmaceuticals Pty Ltd método para tratar osteoartrite; método para tratar uma condição que envolve condrócitos funcionais insuficientes ou tecido cartilaginoso funcional insuficiente; e uso de um peptídeo
US9139626B2 (en) * 2012-09-13 2015-09-22 The Mitre Corporation Mitrecin A polypeptide with antimicrobial activity
SG11202006669RA (en) * 2018-01-15 2020-08-28 Lateral IP Pty Ltd Peptides and uses thereof
KR20220124196A (ko) * 2019-12-27 2022-09-13 레터럴 아이피 피티와이 리미티드 사이클릭 펩티드 수용체 란티오닌 신테타제 c-유사 단백질 (lancl) 및 이의 용도

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2023518376A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)